Cargando…
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
A number of plasma lipid parameters have been used to estimate cardiovascular risk and to be targets for treatment to reduce risk. Most risk algorithms are based on total cholesterol (T-C) or low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), and most inter...
Autores principales: | Wiklund, Olov, Pirazzi, Carlo, Romeo, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751280/ https://www.ncbi.nlm.nih.gov/pubmed/23888382 http://dx.doi.org/10.1007/s11886-013-0397-8 |
Ejemplares similares
-
Management of Lipid Abnormalities in Patients with Diabetes
por: Sillars, Anne, et al.
Publicado: (2019) -
Lipid Screening, Action, and Follow-up in Children and Adolescents
por: Wiegman, Albert
Publicado: (2018) -
Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets: Lipid-lowering combination therapy
por: Masana, Lluís, et al.
Publicado: (2020) -
Optimizing Treatment of Familial Hypercholesterolemia in Children and Adolescents
por: Luirink, Ilse K., et al.
Publicado: (2015) -
Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept
por: Browne, J. L., et al.
Publicado: (2016)